INTERNATIONAL CONTACT LENS SUMMIT (ICLS)
Internationally renowned ophthalmologists, optometrists, and other eye care professionals met to discuss the latest technologies and innovations in contact lenses and anterior segment science at the 2009 International Contact Lens Summit (ICLS). The event, sponsored by the Contact Lens Association of Ophthalmologists (CLAO), was held from September 24-26 at the Hyatt Regency Hotel in beautiful, Canada.
“The Montreal Summit provided an opportunity for ophthalmologists, optometrists, and contact lens professionals from around the world to unite for continuing medical education and to discuss exciting developments in this important vision care field,” said CLAO President Jean Pierre Chartrand, MD. ICLS Co-Chair Daniel Brazeau, OD, stated, “this turned out to be an exceptional meeting for ophthalmologists and optometrists and I have heard many positive comments from our Canadian colleagues who were in attendance.”
Michael Goldstein, MD, MBA, CLAO Scientific Program Chair, observed that the ICLS curriculum was comprehensive. “We developed a unique course schedule that challenged participants with new ideas and concepts in an interesting and thought provoking environment.”
The ICLS included two Keynote Lectureships and two named Lectureships. The CLAO ERF Keynote Lectureship titled “Ocular Surface Disease” was given by Kelly Nichols, OD, PhD, and the ICLS Keynote Lectureship titled “Past, Present, and Future of Contact Lenses” was given by Brien A. Holden, OD, PhD. The Oliver H. Dabezies Jr. Lectureship titled “Multipurpose Contact Lens Solutions: Fact or Folly?” was given by H. Dwight Cavanagh, MD, PhD, and the Harold A. Stein Lectureship titled “Update on Keratoconus and its Management” was given by Florence Malet, MD.
The ICLS meeting was truly international in scope. In addition to CLAO, North America’s leading contacts lens ophthalmological association, other major participating societies and associations from around the world at the ICLS included:
- Japan - Japan Contact Lens Society (JCLS)
- Brazil - Sociedade Brasileira de Lentes de Contato (SOBLEC)
- Europe - European Contact Lens Society of Ophthalmologists (ECLSO)
- Asia Pacific - Asia Pacific Contact Lens Association of Ophthalmologists
|International Contact Lens Ophthalmology Society Leaders
(From left to right) Motozumi Itoi, MD (JCLS), Tania Schaefer, MD (SOBLEC), Jean Pierre Chartrand, MD (CLAO President), Chong Yew Khoo, MD (APCLAO), and Florence Malet, MD (ECLSO).
Two symposia at the ICLS were named In Memoriam for two former CLAO Members. The “New Uses for Contact Lenses Including Contact Lens Delivery of Medications” Symposium was named in memory of J. Pat Cummings, OD, FAAO and the “What’s New in Dry Eye” Symposium was named in memory of Jeffrey P. Gilbard, MD.
Social highlights of the 2009 ICLS featured an International Wine Tasting Reception on Friday, September 25, and a Closing Night Reception at the Montréal Musée d’Art Contemporain on Saturday, September 26.
Support for the International Contact Lens Summit was provided by PLATINUM LEVEL corporate supporters VISTAKON and CIBA Vision, and SILVER LEVEL corporate supporters, ALCON, and BAUSCH & LOMB.
CLAO SYMPOSIUM AT ASCRS 2010
Each year, CLAO presents a symposium on the importance of contact lenses in ophthalmology at the ASCRS Annual Meeting. Topics at next year’s symposium will be as follows: “Update on the Epidemiology of Contact Lenses,” by Michael H. Goldstein, MD, “The Continuum of Care: Contact Lens Applications in the Management of the Disappointed Refractive Surgery Patient,” by Warren R. Fagadau, MD, “Advances in Contact Lenses: Contact Lenses to Deliver Medications,” by Donald J. Doughman, MD, “Giant Papillary Conjunctivitis,” by S. Lance Forstot, MD, and the highlight of the symposium every year is the Richard L. Lindstrom, MD, Lecture. Next year, Michael Raizman, MD will present the lectureship titled “Update on Contact Lens and Allergy.” This CLAO Symposium at ASCRS is currently scheduled for Monday, April 12, 2010 from 8:00 – 9:30 am in the Boston Convention & Exhibition Center.
FDA PLANS LASIK ‘QUALITY OF LIFE’ PROJECT
The Following was Taken From A Press Release:
The U.S. Food and Drug Administration (FDA) announced in October the launch of a collaborative study with the National Eye Institute (NEI) and the U.S. Department of Defense to examine the potential impact on quality of life from LASIK, a surgical procedure that uses an excimer laser to permanently change the shape of the cornea. The goal of the Collaboration Project, the FDA said, “is to determine the percentage of patients with significant quality of life problems after LASIK surgery and identify predictors of these problems.”
Funded by the government agencies, the project has three phases. The objective of Phase 1, which began in July 2009, is to design and implement a Web-based questionnaire to assess patient-reported outcomes and evaluate quality of life issues post-LASIK, some of which may relate to the safety of the lasers used in the LASIK procedure. Phase 2 will evaluate the quality of life and satisfaction following LASIK as reported by patients in a select, active duty population treated at the Navy Refractive Surgery Center. Phase 3 will be a national, multi-center clinical trial and will study the impact of the procedure on quality of life following LASIK in the general population. Patient enrollment in Phases 2 and 3 have yet to begin but plans are underway with Phase 3 expected to end in 2012.
The results of the project will help identify factors that can affect quality of life following LASIK and potentially reduce the risk of adverse effects that can impact the surgical outcome. If any of these factors are related to the safety or effectiveness of the lasers used in LASIK surgery, the FDA will evaluate whether any action is necessary. “This study will enhance our understanding of the risks of LASIK and could lead to a reduction in patients who experience adverse effects from the procedure,” said Dr. Jeffrey Shuren, acting director of the FDA’s Center for Devices and Radiological Health.
The FDA also said it issued warning letters to 17 LASIK ambulatory surgical centers after inspections revealed inadequate adverse event reporting systems at all the centers. The inspections did not identify problems with the use of the LASIK devices at these facilities.
Under legislation passed in 1990, user facilities, which include nursing homes, outpatient clinics, and ambulatory surgical centers, must report device-related deaths to the FDA and to the device manufacturer. They also must report device-related serious injuries to the manufacturer or to the FDA if the manufacturer is not known. Requirements include having a written protocol for adverse event reporting. The FDA inspected ambulatory surgical facilities that perform LASIK over the past several months and additional inspections are pending. The FDA regulates ophthalmic lasers used in LASIK, including monitoring their continued safety and effectiveness by analyzing reports on their post-market use. More information is available at the FDA’s LASIK Web site and at its FDA Guidance for Medical Device Reporting for User Facilities.
Information in this section has been provided to CLAO by press releases and other means. CLAO does not warranty its accuracy; nor does notice of a product in this section constitute an endorsement by CLAO.
Bausch & Lomb announced on October 15 the launch of a novel, interactive portal to support its new Center for Patient Insights atwww.CenterForPatientInsights.com. The Center, initiated in June, delivers news, insights, and trends to eye care professionals to help them better understand and meet patient needs. The Web site will aggregate this critical information and serve as an easy-to-use point of entry for eye care professionals and will provide eye care professionals with brief PatientPoints, which provide summaries of industry trends; market research on patient attitudes and beliefs; and insights on how these data can be used to improve their practices. Information can be downloaded from the Web site and printed for future reference. A search function is also available which will allow users to easily locate specific information via keywords and categories, including vision conditions, patient outcomes, and patient preferences. In addition to its Web site, the Center for Patient Insights will use a variety of channels, including publications and e-mails, to distribute timely, relevant, and comprehensive data gathered from patient and consumer research.
CooperVision announced on October 13 that it has unveiled its LensLocatorSM, a first of its kind online tool that allows doctors to easily search across CooperVision’s extensive portfolio of contact lenses to identify the most appropriate choices in seconds rather than several minutes. The LensLocator can be accessed by practitioners from a computer or Web-enabled smart phone at www.LensLocator.com. Doctors simply enter a patient’s specific prescription, or any component of a prescription—such as sphere power, cylinder power, axis, ADD, modality, and wear schedule—into the LensLocator fields and then click on the search button. The tool automatically scans the entire CooperVision portfolio, ranging from spheres to multifocal toric lenses, and identifies options that contain all of the necessary information practitioners need to fit the patient. The site also provides a direct link to MyCooperVision, the company’s secure e-commerce site, so that doctors can immediately place an order for the lenses.
To further speed quality care at the time and point of need, CooperVision’s LensLocator tool has been designed to support the multiple ways that eye care professionals are working today. It will work on Web-capable smart phones and devices, including the iPhone® and iPod touch®, allowing eye care professionals to access a comprehensive list of CooperVision products while moving through a busy office, after hours, or off-site. The LensLocator is also accessible through CooperVision’s practitioner website, www.coopervision.com.
To help kick off the new site, CooperVision will be donating a dollar to New Eyes for the Needy for each unique visitor to LensLocator.com, up to $5,000. Endorsed by the American Academy of Optometry, New Eyes for the Needy is a non-profit volunteer organization that helps improve vision by providing new and recycled eyeglasses to children and adults worldwide.
About New Eyes for the Needy: New Eyes for the Needy is a non-profit, non-sectarian volunteer organization that purchases new eyeglasses for poor children and adults in the United States and recycles donated glasses for distribution to indigent people in developing nations worldwide. The agency was established in 1932. Since then, New Eyes for the Needy has brought improved vision and hope for a better future to more than 7,000,000 people in the U.S. and around the world. For more information, visit www.neweyesfortheneedy.org.
MARK YOUR CALENDAR
The 5th International Conference on Ocular Infections will be held on February 18-21, 2010 at the Breakers Resort, Palm Beach, USA. For more information about the Symposium, visit the website at www.paragon-conventions.com/icoi2010.
CLAO "DID YOU KNOW?":
The ICLS Meeting was the first major contact lens meeting that CLAO has held in Canada.